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S U M M A R Y
African tick-bite fever (ATBF) is a newly described spotted fever rickettsiosis that frequently presents
with multiple eschars in travelers returning from sub-Saharan Africa and, to a lesser extent, from the
West Indies. It is caused by the bite of an infected Amblyomma tick, whose hunting habits explain the
typical presence of multiple inoculation skin lesions and the occurrence of clustered cases. The
etiological agent of ATBF is Rickettsia africae, an emerging tick-borne pathogenic bacterium.We describe
herein a cluster of ﬁve cases of ATBF occurring in Swiss travelers returning from South Africa. The co-
incidental infections in these ﬁve patients and the presence of multiple inoculation eschars, two features
pathognomonic of this rickettsial disease, suggested the diagnosis of ATBF. Indeed, the presence of at
least one inoculation eschar is observed in 53–100% of cases and multiple eschars in 21–54%. Two
patients presented regional lymphadenitis and one amild local lymphangitis. Though a cutaneous rash is
described in 15–46% of cases, no rash was observed in our series. ATBF was conﬁrmed by serology. Thus,
ATBF has recently emerged as one of the most important causes of ﬂu-like illness in travelers returning
from Southern Africa. The presence of one or multiple eschars of inoculation is an important clinical clue
to the diagnosis. It can be conﬁrmed by serology or by PCR of a biopsy of the eschar. Culture can also be
done in reference laboratories. Dermatologists and primary care physicians should know this clinical
entity, since an inexpensive and efﬁcient treatment is available.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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African tick-bite fever (ATBF) is an important emerging
infectious disease transmitted by ticks. The disease was ﬁrst
discovered in 1930.1,2 At that time, Pijper isolated the agent,2 but
the isolate was lost. The causative agent was again isolated from
humans in 1990,3 and named Rickettsia africae in 1996.4 The vector
is speciﬁc. Amblyomma variegatum is the tick transmitting R. africae
in the sub-Saharan area and Amblyomma hebraeum is found more
speciﬁcally in South Africa.5,6 Some cases have also been described
in the West Indies,7 probably also transmitted by Amblyomma
ticks. Amblyomma is one of the genera assigned to the Ixodidae
family of ticks. These ticks have a hard sclerotized dorsal plate. The
three developmental stages (adult, nymph, and larva) of the tick* Corresponding author. Tel.: +41 21 3144979; fax: +41 21 3144060.
E-mail address: gilbert.greub@chuv.ch (G. Greub).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.11.021may transmit R. africae. Cattle are the most important domestic
hosts, although sheep, horses, donkeys, pigs, giraffes, buffalos,
antelopes, and warthogs are also frequently attacked.8
The hunting strategy of Amblyomma spp differs from other ticks
in that they do no wait passively on vegetation, but emerge from
their habitat, with several ticks ‘running’ towards a host when it
appears nearby.9 They are highly responsive to stimuli such as CO2
concentration, NH3, humidity, aromatic chemicals, airborne
vibration, and body temperature. This explains the clinical
presentation of multiple eschars and the typical occurrence of
clustered cases.10 Another spotted fever group Rickettsia, Rickettsia
conorii, the causative agent of the Mediterranean spotted fever is
also present in South Africa.11 However, R. conorii, in contrast to R.
africae, is transmitted by ticks that only infrequently bite humans
(mainly Rhipicephalus sanguineus), and that almost never cause
multiple inoculation eschars.
R. africae is present in about 50% of Amblyomma ticks, which
represents a high contamination rate.5 The human is an accidentalses. Published by Elsevier Ltd. All rights reserved.
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returning travelers, hunting as the purpose of travel and staying in
a rural area were the two factors signiﬁcantly associated with
seropositivity.12 The prevalence of seropositive individuals in the
areas endemic for the ticks is unknown, but may be as high as
80%.13 The prevalence among travelers has been the topic of a few
studies. Jensenius et al. estimated the prevalence at 4.0–8.6%.12
The incubation period is typically 5–10 days.13 Fifty-three to
100% of the patients present with at least one eschar at the site of
inoculation, and 21–54% have multiple lesions.13 Regional
lymphangitis is found in 43–100% of cases, and a cutaneous rash
can be maculopapular (15–26%), vesicular (0–21%), or absent.13
Aphthous stomatitis is less frequent (11%). The other frequent
symptoms are fever, headache, neck muscle pain, and general
myalgia.13 Neuropsychiatric symptoms have recently been
described in two Swiss patients.14 Moreover, severe complications
such as myocarditis15 and sub-acute neuropathy16 have also been
reported, especially in elderly patients.17
The most commonly used antibiotic is doxycycline 100 mg
twice daily for 7 days or for 48 h after resolution of fever.13
2. Report of cases
In April 2004, ﬁve patients who had traveled through South
Africa over the course of 18 days attended our travel clinic, ﬁve
days after their return to Switzerland. They complained of ﬂu-like
symptoms and eschars at the site of presumed inoculation.
The ﬁve patients had traveled together in South Africa. They
started with 7 days in Cape Town and then went to Durban and
spent 7 days in two game parks, Santa Lucia and Nibela. They then
returned to Cape Town for a further 5 days. All of them noticed
bites on day 13 from the start of their holiday. These bites, thought
to have been due to a ‘big mosquito’ evolved into typical
inoculation eschars (Figure 1). All developed a ﬂu-like syndrome
6–10 days later, which included fever (n = 4), headache (n = 4),
myalgia (n = 2), and/or shivers without fever (n = 1). None of the
patients described any recent cutaneous rash and no rash was
observed during clinical examination. A local lymphadenitis was
present in two patients. One patient presented a painful escharFigure 1. Skin lesions: (A) Several eschars of inoculation (yellow arrows) present on the le
Patient 1 presented an eschar on the ventral part of the arm (arrow) and a lymphangitis
(patient 2).with lymphangitis (Figure 1C), which was empirically treated with
amoxicillin–clavulanate from day 20 onwards, prescribed by her
private practitioner. All group members presented to the
University Hospital, Lausanne for the ﬁrst time on day 23, 5 days
after their return from South Africa. All were healthy without any
signiﬁcant medical history prior to travel.
White blood cell counts ranged from 4 to 7.6  109/l, thrombo-
cytes from 163 to 329  109/l, and C-reactive protein from 2 to
29mg/l. Hepatic enzymes were slightly increased in two patients.
Immunoﬂuorescence was performed at the Unite´ des Rickettsies
(Marseille, France) on a ﬁrst serum sample drawn on day 23 (so-
called acute-phase serum) and on a second sample taken 3–5
months later (convalescent-phase serum). The cut-off titers used
were 1/64 for IgM and 1/128 for IgG. The acute sera taken from
two patients already exhibited some anti-rickettsial reactivity, with
IgM titers of 1/32 and 1/64. A third patient with a negative acute
serum for both IgG and IgM seroconverted with an IgM titer of 1/32
and IgG titer of 1/256 in the convalescent serum. A fourth patient
whose acute serum was negative for both IgM and IgG showed a
slight elevation of IgG titer in his convalescent serum. A ﬁfth patient
who already exhibited an IgM titer of 1/64 (but no IgG) in the acute
phase serum seroconverted for IgG with an IgG titer of 1/128 in the
convalescent serum. Cross-reactivities between spotted-fever
Rickettsia was observed with similar IgG titers against R. africae,
R. slovaca, R. helvetica, R. massiliae, R. aeschlimannii, R. mongoloti-
monae, (Rickettsia israelensis), R. felis and R. conorii. No cross-
adsorption was done given the low antibody titers.
3. Discussion
We have reported ﬁve cases of ATBF in travelers who had
spent their holidays in South Africa. All patients presented
typical eschar(s) at the site of inoculation, also called ‘tache
noire’ in French. In the presence of such eschars, medical doctors
should strongly consider an infection by a spotted fever group
Rickettsia. Furthermore, the presence of multiple eschars and
grouped cases strongly suggests the diagnosis of African tick-
bite fever due to R. africae, given the hunting strategy of its
vector, the Amblyomma tick.9,10ft leg of patient 5. (B) Closer view of the eschar located posterior to the knee joint. (C)
(arrowhead). (D) Eschar on the left cheek (patient 3). (E) Eschar on the right groin
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supported by serological evidence of a recent infection (IgM or
seroconversion) in three of the ﬁve patients. The absence of
detectable antibody reactivity in two patients is in line with the
observed delayed increase in antibody titers following R. africae
infection, as compared to infections by R. conorii.18 Due to cross-
reactivities with other spotted group Rickettsia, immunoﬂuores-
cence failed to identify the exact Rickettsia involved here.
However, the diagnosis of ATBF due to R. africae was retained
based on the occurrence of clustered cases and of multiple eschars
in one patient, two features pathognomonic of the disease. Of note,
a speciﬁc diagnosis of R. africae infectionmay be established in 73%
of patients usingWestern blot and cross-adsorption assays (versus
15% with immunoﬂuorescence only).19 However, in our cases, the
low antibody titers precluded a detailed serological analysis.
PCR of a biopsy of the eschar is an alternativeway to conﬁrm the
diagnosis of ATBF. To achieve an optimal sensitivity, a speciﬁc
nested PCR can be used.20 Since the ADP/ATP-translocase – an
energy parasite enzyme – is only present in Rickettsiales,
Chlamydiales, and plant plastids,21 PCR ampliﬁcation with primers
targeting the ADP/ATP-translocase encoding gene may be associ-
ated with higher speciﬁcity than PCR targeting highly conserved
genes such as 16SrDNA. Using speciﬁc PCRs is especially important
due to the risk of unspeciﬁc ampliﬁcation of other bacteria that
commonly colonize the skin.
Culture of skin biopsy is another way to obtain a precise
etiological diagnosis.10 However, given the obligate intracellular
lifestyle of Rickettsia spp, this approach is restricted to some
specialized laboratories that routinely use cell culture to detect
intracellular bacteria from clinical samples.
We did not perform a skin biopsy because the clinical and
epidemiological conditions found in these patients were sufﬁ-
ciently speciﬁc to allow avoidance of an invasive procedure.
Atypical clinical presentation (isolated case, single eschar),
unexpected geographical area of infection, and severity of the
clinical course are the main reasons for performing this invasive
procedure for diagnosis.22
Other causes of eschars in travelers returning from Africa
include relapsing fever, plague, anthrax, or trypansomiasis.23
These diseases are fairly rare and the most common cause of
lesions that look like an eschar are related to mosquito bites or any
other bites that get superinfected with common bacteria such as
staphylococci (see www.fevertravel.ch for the detailed differential
diagnosis of febrile illness associated with rash, ulcers, or eschars).
In conclusion, we have reported a cluster of ﬁve cases of spotted
fevergroup rickettsiosis probablydue toR. africae. Thedestinationof
the trip (South Africa), the type of activity undertaken (walk in a
game park), and the clinical features (ﬂu-like syndrome associated
with 1–3 eschars) allowed us to make the diagnosis on the
telephone. The absence of rash in all our patients was an usual
clinical ﬁnding, since rash is observed in 15–46% of patients with
African tick-bite fever.10,12,13Moreover, the rash canbemissed since
it is oftenmild.Thisdisease,which remainedunrecognized foryears,
should be included in the differential diagnosis of skin lesions,
especially eschars, associated with a febrile illness occurring in
travelers returning fromendemic areas (especially Southern Africa).Conﬂict of interest
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